128 related articles for article (PubMed ID: 31808857)
1. Evidence-Based Minireview: Longitudinal geriatric assessment in quality care for older patients with hematologic malignancies.
Lin RJ; Klepin HD
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):59-62. PubMed ID: 31808857
[TBL] [Abstract][Full Text] [Related]
2. Function, Survival, and Care Utilization Among Older Adults With Hematologic Malignancies.
DuMontier C; Liu MA; Murillo A; Hshieh T; Javedan H; Soiffer R; Stone RM; Driver JA; Abel GA
J Am Geriatr Soc; 2019 May; 67(5):889-897. PubMed ID: 30945759
[TBL] [Abstract][Full Text] [Related]
3. Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care.
Olin RL
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):63-70. PubMed ID: 31808886
[TBL] [Abstract][Full Text] [Related]
4. Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: a GOELAMS study.
Guièze R; Cornillet-Lefebvre P; Lioure B; Blanchet O; Pigneux A; Recher C; Bonmati C; Fegueux N; Bulabois CE; Bouscary D; Vey N; Delain M; Turlure P; Himberlin C; Harousseau JL; Dreyfus F; Béné MC; Ifrah N; Chevallier P;
Am J Hematol; 2012 Dec; 87(12):1052-6. PubMed ID: 22911473
[TBL] [Abstract][Full Text] [Related]
5. Decision Analysis of Postremission Therapy in Cytogenetically Intermediate-Risk Acute Myeloid Leukemia: The Impact of FLT3 Internal Tandem Duplication, Nucleophosmin, and CCAAT/Enhancer Binding Protein Alpha.
Kurosawa S; Yamaguchi H; Yamaguchi T; Fukunaga K; Yui S; Wakita S; Kanamori H; Usuki K; Uoshima N; Yanada M; Shono K; Ueki T; Mizuno I; Yano S; Takeuchi J; Kanda J; Okamura H; Inamoto Y; Inokuchi K; Fukuda T
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1125-1132. PubMed ID: 27040395
[TBL] [Abstract][Full Text] [Related]
6. Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care.
Olin RL
Blood; 2019 Dec; 134(23):2013-2021. PubMed ID: 31805199
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD.
Ho AD; Schetelig J; Bochtler T; Schaich M; Schäfer-Eckart K; Hänel M; Rösler W; Einsele H; Kaufmann M; Serve H; Berdel WE; Stelljes M; Mayer J; Reichle A; Baldus CD; Schmitz N; Kramer M; Röllig C; Bornhäuser M; Thiede C; Ehninger G;
Biol Blood Marrow Transplant; 2016 Mar; 22(3):462-9. PubMed ID: 26551637
[TBL] [Abstract][Full Text] [Related]
8. The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia.
Klepin HD; Geiger AM; Tooze JA; Kritchevsky SB; Williamson JD; Ellis LR; Levitan D; Pardee TS; Isom S; Powell BL
J Am Geriatr Soc; 2011 Oct; 59(10):1837-46. PubMed ID: 22091497
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic significance of early assessment of minimal residual disease in acute myeloid leukemia with mutated NPM1 patients].
Zhao T; Zhu HH; Wang J; Jia JS; Yang SM; Jiang H; Lu J; Chen H; Xu LP; Zhang XH; Jiang B; Ruan GR; Wang DB; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2017 Jan; 38(1):10-16. PubMed ID: 28219218
[No Abstract] [Full Text] [Related]
10. Hematopoietic transplantation for acute myeloid leukemia with internal tandem duplication of FLT3 gene (FLT3/ITD).
Brunet S; Martino R; Sierra J
Curr Opin Oncol; 2013 Mar; 25(2):195-204. PubMed ID: 23385863
[TBL] [Abstract][Full Text] [Related]
11. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
Schlenk RF; Döhner K; Krauter J; Fröhling S; Corbacioglu A; Bullinger L; Habdank M; Späth D; Morgan M; Benner A; Schlegelberger B; Heil G; Ganser A; Döhner H;
N Engl J Med; 2008 May; 358(18):1909-18. PubMed ID: 18450602
[TBL] [Abstract][Full Text] [Related]
12. Effect of Intensive Chemotherapy on Physical, Cognitive, and Emotional Health of Older Adults with Acute Myeloid Leukemia.
Klepin HD; Tooze JA; Pardee TS; Ellis LR; Berenzon D; Mihalko SL; Danhauer SC; Rao AV; Wildes TM; Williamson JD; Powell BL; Kritchevsky SB
J Am Geriatr Soc; 2016 Oct; 64(10):1988-1995. PubMed ID: 27627675
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia patient with
Huang Y; Hu J; Lu T; Luo Y; Shi J; Wu W; Han X; Zheng W; He J; Cai Z; Wei G; Huang H; Sun J
Cancer Manag Res; 2019; 11():4129-4142. PubMed ID: 31190985
[No Abstract] [Full Text] [Related]
14. Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia.
Scholl S; Theuer C; Scheble V; Kunert C; Heller A; Mügge LO; Fricke HJ; Höffken K; Wedding U
Eur J Haematol; 2008 Mar; 80(3):208-15. PubMed ID: 18081718
[TBL] [Abstract][Full Text] [Related]
15. Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio.
Versluis J; In 't Hout FE; Devillier R; van Putten WL; Manz MG; Vekemans MC; Legdeur MC; Passweg JR; Maertens J; Kuball J; Biemond BJ; Valk PJ; van der Reijden BA; Meloni G; Schouten HC; Vellenga E; Pabst T; Willemze R; Löwenberg B; Ossenkoppele G; Baron F; Huls G; Cornelissen JJ
Leukemia; 2017 Jan; 31(1):26-33. PubMed ID: 27416910
[TBL] [Abstract][Full Text] [Related]
16. T-cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3-ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Canaani J; Labopin M; Huang XJ; Arcese W; Ciceri F; Blaise D; Irrera G; Corral LL; Bruno B; Santarone S; Van Lint MT; Vitek A; Esteve J; Mohty M; Nagler A
Am J Hematol; 2018 Jun; 93(6):736-744. PubMed ID: 29498106
[TBL] [Abstract][Full Text] [Related]
17. Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: Report of CALGB 361006 (Alliance).
Klepin HD; Ritchie E; Major-Elechi B; Le-Rademacher J; Seisler D; Storrick L; Sanford BL; Marcucci G; Zhao W; Geyer SA; Ballman KV; Powell BL; Baer MR; Stock W; Cohen HJ; Stone RM; Larson RA; Uy GL
J Geriatr Oncol; 2020 Jan; 11(1):107-113. PubMed ID: 31668825
[TBL] [Abstract][Full Text] [Related]
18. Ready for prime time: role for geriatric assessment to improve quality of care in hematology practice.
Klepin HD
Blood; 2019 Dec; 134(23):2005-2012. PubMed ID: 31805198
[TBL] [Abstract][Full Text] [Related]
19. Tailoring Therapy in Older Adults With Hematologic Malignancies.
Mangan BL; DuMontier C; Hopkins JO; Abel GA; McCurdy SR
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432220. PubMed ID: 38788182
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia.
Shamaa S; Laimon N; Aladle DA; Azmy E; Elghannam DM; Salem DA; Taalab MM
Hematology; 2014 Jan; 19(1):22-30. PubMed ID: 23540998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
